Abstract: At present no clear-cut physiologic/serological parameter exist which enable an early identification of neonates who are at increased risk to develop myocardial dysfunction in perinatal asphyxia. This study was conducted to find out the incidence and features of cardiac dysfunction in perinatal asphyxia The present study was carried out on 48 neonates ,17 healthy neonates were taken as controls while 31 neonates with perinatal asphyxia enrolled within 72 hours of birth as cases. Electrocardiographic, echocardiographic and biochemical parameters were obtained in all subjects and were correlated with the severity of disease and its outcome. Mean CK-MB level in neonates with perinatal asphyxia was 15.18 ng/ml while mean value in control group was 2.9 ng/ml(p< 0.001). Mean CK-MB values in Stage 1, stage 2 and stage 3 of Hypoxic Ischemic Encephalopathy (HIE) were 8.69 ± 2.85 ng/ml, 11.03 ± 4.46 ng/ml and 24.85 ± 19.13 ng/ml, respectively(p< 0.001). Mean Troponin-I value in neonates with perinatal asphyxia was 0.18 ng/ml, while mean value in control group was 0.02 ng/ml (p< 0.001) Mean Troponin I values in Stage 1, stage 2 and stage 3 were 0.09 ± 0.04 ng/ml, 0.17 ± 0.07 ng/ml and 0 .26 ± 0.08 ng/ml, respectively (p< 0.001). Mean BNP level in neonates with perinatal asphyxia was 1111.2 ± 663.1 pg/ml while in control group it was 253.2 ± 86.1 pg/ml(p< 0.001). Mean BNP Values in Stage 1, stage 2 and stage 3 were 482.40 ± 114.83 pg/ml, 957.00 ± 336.94 pg/ml and 1823.27 ± 477.91 pg/ml, respectively(p< 0.001). CK-MB, cTnI and BNP levels were significantly higher among vasopressor recipients as compared to the non-recipients (p value < 0.01, <0.001, and < 0.001, respectively) Neonates who died had significantly higher level of CK-MB, cTnI and BNP (p value <0.001, <0.05 and <0.05 respectively) in comparison to patients who recovered and discharged. Significantly lower values of RVEF and LVEF were found with increasing grades of HIE (p<0.05 and <0.05 respectively). Myocardial dysfunction secondary to perinatal asphyxia is much more frequent than thought and it requires high index of suspicion. Thus, an early detection of myocardial dysfunction and prompt cardiovascular support will help in improving prognosis of these asphyxiated newborns.
INTRODUCTION
Birth asphyxia is defined by the World Health Organization as "the failure to initiate and sustain breathing at birth immediately after delivery" (WHO) [1] .This has been associated with hypoxic-ischemic injury to the central nervous system (CNS) and the clinical manifestations of this injury have been termed as Hypoxic Ischemic Encephalopathy (HIE). Perinatal asphyxia is a common problem with the incidence varying from 0.5 -2% of live births [2, 3] . It is an important cause of morbidity and mortality and a frequent cause of admission to neonatal intensive care units (NICU).
In India, in rural regions of the Uttar Pradesh [4] and Maharashtra [5] 23% and 25% of neonatal mortality were attributed to birth asphyxia, respectively. Hospital-based studies in Nepal [6] and South Africa [7] estimated that birth asphyxia accounted for 24% and 14% of perinatal mortality, respectively.
As per the statements by the American College of Obstetricians and Gynecologist and the American Academy of Pediatrics, a neonate is labeled to be asphyxiated if the following conditions are satisfied:
 Umbilical cord arterial pH less than 7;  Apgar score of 0 to 3 for longer than 5 minutes;  Neonatal neurologic manifestations (e.g. seizures, coma, or hypotonia); and
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 Multisystem organ dysfunction, e.g. cardiovascular, gastrointestinal, hematologic, pulmonary, or renal system. Hypoxic ischemic organ damage can occur at antepartum prenatal asphyxia (50%), at intrapartum perinatal (birth) asphyxia (40%) or after delivery as postpartum asphyxia (10%) [8] . Acute maternal infections, pre-maturity of a newborn and multiple births are the most frequent natural risk factors leading to hypoxic conditions in a fetus or newborn.
Severe birth asphyxia results in myocardial ischemic injury. The incidence of clinical cardiac dysfunction in perinatal asphyxia varies from 24-31 %. Myocardial involvement leading to cardiogenic shock remains one of the commonest challenges in management and significant cause of mortality in neonates suffering from perinatal asphyxia. Clinically cardiac dysfunction in perinatal asphyxia manifest as: respiratory distress, congestive heart failure, triscupid insufficiency and myocardial ischemia leading to cardiogenic shock.
Electrocardiographic and echocardiographic studies have been done to study cardiac dysfunction in perinatal asphyxia. Associated ECG changes are T wave inversion, T wave flattening, ST segment depression and significant Q wave indicating infarction. Echocardiographic findings include tricuspid regurgitation, mitral regurgitation, right and left ventricular hypokinesia and ventricular dilatation [9] .
CPK-MB has been found to be both very specific and very sensitive for diagnosing acute MI in adults until recently being replaced by highly selective troponins [10, 11] . It has been found that levels of CK-MB correlate well with degree of myocardial involvement in perinatal asphyxia in neonatal period and associated with poor outcome [12] .
Cardiac troponin I (cTnI) is thought to be an indicator of perinatalasphyxia-induced myocyte damage [13] . Cardiac troponin I (cTnI) concentration within 36 hr of birth correlate strongly with severity of myocardial dysfunction, clinical grade of HIE and with duration of inotropic support. It has been seen that early cTnI concentrations may provide a useful marker for the anticipated severity of myocardial dysfunction in asphyxiated neonates [14] .
Btype natriuretic peptide (brain natriuretic peptide; BNP)is a cardiac hormone with diuretic, natriuretic, and vasodilator properties [15] .This is secreted mainly in the ventricles inresponse to volume expansion and pressure load. Both BNP and troponin I are elevated in preterm infants with a significant patent ductusarteriosus [16, 17] and both have been used to evaluate the response to treatment of congenital heart disease [18] . BNP is elevated in persistent pulmonary hypertension of the newborn and correlates well with the pressure gradient across the tricuspid valve [19] and therefore is a useful marker in infants with persistent pulmonary hypertension of the newborn following perinatal asphyxia. Also cord blood BNP is significantly elevated in infants requiring inotropes following perinatal asphyxia [20] .
Myocardial involvement in perinatal asphyxia remains one of the commonest challenges in management and significant cause of mortality. The exact incidence of occurrence of various electrocardiaographic and echocardiographic findings in studies done earlier by various authors differ markedly. Factors leading to respiratory distress per se, like transient tachypnea of newborn, birth trauma, increased intracranial tension and use of drugs which suppress myocardium, like phenobabitone given in high dose to control refractory seizure pose problem in finding out the exact incidence of cardiac dysfunction due to birth asphyxia. Also not much data is available whether the cardiac changes and mortality is affected by sex, birth weight or mode of delivery. CK-MB, cardiac troponin I and BNP testing is central to the diagnosis of acute myocardial infarction in adults. But there are few data in neonates about the efficacy of these enzymes as a marker of cardiac dysfunction in perinatal asphyxia and as a predictor of future outcome and/or mortality. At present no clear-cut physiologic/serological parameter exist which enable an early identification of neonates who are at increased risk to deveope myocardial dysfunction in perinatal asphyxia.
This study was conducted with following objectives :
1. To find out the incidence and features of cardiac dysfunction in perinatal asphyxia 2. To evaluate the role of cardiac enzyme CK-MB, Troponin I and BNP as a marker of cardiac dysfunction in perinatal asphyxia. Two ml of venous blood was collected by venepuncture in EDTA vials. Whole blood specimens were tested within 1 hour of sample collection. If testing could not be completed within 1 hour, the plasma was separated and tested within 2 hours from the time of collection or frozen at ≤ -20 ºC until it could be tested. A chest X-ray was taken in all patients enrolled in this study. Blood from patient was also analyzed for other hematological and biochemical investigations like hemoglobin, total leucocyte count, urea, creatinine, sodium, potassium, calcium and blood sugar etc.
MATERIALS AND METHODS
Data was collected in predesigned data sheet and entered in Microsoft Excel Worksheet 2007 and analyzed using SPSS 11.5 statistical software. Demographic parameters of neonates between case and controls were compared by Student's t test and proportions by Chi-Square test and Fischer exact test.
Comparison of biochemical parameters and findings of 2D Echocardiography were made by analysis of variance (ANOVA). The parameters were compared between control and neonates having various stages of HIE. A p value of < 0.05 was considered as statistical significance.
RESULTS
The present study was carried out on 48 neonates ,17 healthy neonates were taken as controls while 31 neonates with perinatal asphyxia enrolled within 72 hours of birth as cases. Out of 31 neonates, 10 each was in HIE stage 1 and 2 while 11 were in HIE stage 3.
Demographic data
The demographic data of the study population along with control is presented in Table 1 . No significant difference was seen between case and control with respect to parameters like sex, gestational age, crown heel length (CHL), occipital frontal circumference (OFC), maternal registration status, maternal age, maternal weight and antenatal complications. However, mean birth weight was significantly higher in perinatal asphyxia group(p< 0.05).
Demographic data according to various stages of HIE is presented in 
Clinical details of the cases with perinatal asphyxia:
The clinical details of study subjects are presented in Table 5 No significant difference was found among neonates in three groups with respect to RV dilation or LV dilation. Neonates who died had significantly higher level of CK-MB, cTnI and BNP (p value <0.001, <0.05 and <0.05 respectively) in comparison to patients who recovered and discharged (table 14) . 
DISCUSSION
In present study was carried out 31 neonates with perinatal asphyxia admitted to the Neonatal Unit, Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi. For delivery room resuscitation, the standard NRP AAP 2010 guidelines were followed. All the cases were enrolled within 72 hours of birth. The cases were further divided into HIE stage 1 (n=10), HIE stage 2 (n=10) and HIE stage 3 (n=11) according to Sarnat et al. ; [21] staging.
Demographic parameters
Demographic parameters including maternal age and weight, antenatal care, gestational age, gender, crown rump length, and occipital-frontal circumference, was evenly distributed between case and control groups. Neonatal weight was higher among asphyxiated neonates (p<0.05). Probably larger sized babies were associated with more obstetric complications.
In present study, nine deliveries were by spontaneous vaginal delivery while 8 were by caesarean section among control group. Among cases, sixteen deliveries were by spontaneous vaginal delivery while 14 were by caesarean section and one was instrumental delivery. No significant difference was observed with respect to mode of delivery between case and control groups. Also no significant association of mode of delivery (p= 0.123) was found with different stages of HIE. Meconium stained amniotic fluid was present in 13 (41.93 %) cases. Similar incidence was found in the study of Martin-Ancel et al.; [23] , where the authors documented an incidence of 42%.
Clinical presentation
In present study respiratory distress was most common finding to be present in seventeen (54.83%) neonates followed by cardiogenic shock in 13(41.93%) neonates. None of the neonates had congestive heart failure. In study done by Rajakumar et al.; [9] incidence of respiratory distress among asphyxiated neonates was 66.7% followed by congestive heart failure in 36.7% and shock in 16.7%. However, none of the neonate had congestive heart failure in study by Martin-Ancel et al.; [23] which is consistent with findings of present study. In present study, cardiogenic shock was present in 13 (41.93%) asphyxiated neonates which is comparable to 44 % incidence in study by Mandal et al.; [24] .
. In presents tudy, chest X-ray was abnormal in 10 (32.25%) neonates. Features suggestive of meconium aspiration syndrome were most common finding to be present in 5 (16.12 %) neonates. Four neonates in HIE stage 3 group had X-ray features suggestive of meconium aspiration syndrome. Five chest X rays showed bilateral infiltrates suggestive of pneumonia.
In a study done by Martin-Ancel et al.; [23] , 19% of neonates had clinical seizures, contradictory to Shah et al.; [25] who documented presence of seizure or coma in 87% neonates. In present study, clinical seizure was documented in 16 (51.61%) neonates and renal involvement was present in 13 (41.93%) neonates. Moderate to severe renal involvement was documented in 42% of neonates by Martin-Ancel et al.; [23] , which is similar to present study.
Cretinine kinase-MB (CK-MB)
In present study, mean CK-MB level (15.18±13.58 ng/ml) in cases was significantly higher than that of the controls (2.90 ± 1.48 ng/ml) (p<0.001). Mean value of CK-MB in Stage 3 was significantly higher as compared to stage 2 and stage 1 (p< 0.01 and <0.001, respectively), while it was comparable between Stage 2 and Stage 1. This finding is similar to previous study done by Rajakumar et al. ; [9] who reported higher CK-MB values in asphyxiated neonates. Chauhan et al.; [26] also found very high correlation between clinical pattern of asphyxiated newborn infants and alterations of serum cardiac enzyme CK-MB.
Cardiac troponin I (cTnI)
Present study showed a statistically significant higher value of cTnI among asphyxiated neonates than control group (p< 0.001). Also significantly higher levels of cTnI were observed with increasing grades of HIE(p< 0.001). This finding is consistent to observations of Simovic et al.; [27] and Shastri et al.; [14] . Trevisanuto et al.; [13] concluded in their study that in asphyxiated neonates, cTnI concentrations are higher with respect to healthy infants. Also Fang et al.; [28] demonstrated that CK-MB and cTnI levels were significantly higher in asphyxiated neonates than control group.
Brain natriuretic peptide (BNP)
In present study, mean BNP levels in asphyxia group was significantly higher than control group (p< 0.001). Moreover highest BNP levels were found in HIE stage 3 subgroup followed by HIE stage 2 and Stage 1 group (p< 0.001). In present study, mean BNP level in control group was 253.24 pg/ml which was similar to value of 231.6pg/ml as documented by Koch et al.; [29] .
Mean BNP was highest in HIE stage 3 group suggesting the severity of myocardial injury. In this group, 7 neonates required vasopressor support (mean duration 68.14 hrs) while lowest value was found in HIE stage 1 group in which only 2 neonates required vasopresssor support (mean duration 37.5 hrs). BNP levels were significantly higher in vasopressor recipient neonates than non recipients (p< 0.001). Few studies have been done previously which correlate need of vasopressor support in asphyxiated neonates with BNP levels. This finding is consistent with previous studies by Moriichi et al.; [20] who found that cord blood BNP was significantly elevated in asphyxiated neonates requiring inotropes.
Thus findings of present study are consistent with previous reports that asphyxia in the newborns leads to myocardial injury as detected by CK-MB, cTnI and BNP. These markers may be useful in anticipating cardiac dysfunction and providing appropriate cardiovascular support in addition to managing the primary condition.
ECG
ECG was abnormal in twenty one (67.75%) neonates in case group. Most ECG changes were of Grade 1 (29.03 %) followed by Grade 2 (16.12%) and grade 3 (12.90%). Grade 4 change was present in only one neonate in HIE stage 3 group. In study done by Rajakumar et al.; [9] , ECG changes were present in 73.3% of asphyxiated neonates which is comparable to present study. However, Grade 2 ECG changes were most common abnormality reported by the authors . Echocardiography RVEF and LVEF were comparable in case and control population. However, values were significantly lower in HIE stage 3 as compared to HIE stage 2 and HIE stage 1 (p<0.05 and p< 0.05 respectively). In contrast, Rajakumar et al.; [9] reported significant differences in cardiac contractility between case and control group.
Ischemic injury to cardiac papillary muscle and PPHN both can lead to valvular regurgitation and regurgitant murmurs. In present study, tricuspid regurgitation was most common valvular lesion, present in 11 (35.48%) followed by mitral regurgitation in 7 (22.58%) neonates. The incidence of tricuspid regurgitation was 23.3% (most common) in study done by Rajakumar et al.; [9] . Incidences of TR as documented by Rowe et al.; [2] , Flores et al.; [3] and Martin-Ancel et al.; [23] were 12%, 7% and 21%, respectively. The wide variation in the incidence of TR may be due to the type of cases selected, presence or absence of pulmonary hypertension and the timing of echocardiography.
CONCLUSION:
In general, cardiac abnormalities often are underdiagnosed and require a high index of suspicion. The measurement of CK-MB, cardiac troponin I and BNP as evidenced by present study may have a role in the early identification of neonates with myocardial damage secondary to ischemia.
In present study, there is a clear relationship between clinical pattern of asphyxiated newborn infants and alterations of enzymatic, electrocardiographic and echocardiographic parameters. Neonates with severe hypoxic damage was reflected in significant changes in ECG , echocardiography and enzyme levels.
Thus, it can be concluded that myocardial dysfunction secondary to perinatal asphyxia is much more frequent than thought, for which it will also be useful to submit asphyxiated patients to serial ECG monitoring, echocardiographic assessments and CK-MB, Troponin I and BNP level measurements. The early detection and prompt cardiovascular support will help in improving prognosis of these asphyxiated newborns.
